800-872-2273

Clinical Trials and Studies

Your participation matters. Help us discover and cure!

Contact us at (800) USC-CARE (800-872-2273)

We're sorry, but this trial is no longer enrolling volunteers.

Description

Phase

Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.

Inclusion and Exclusion Criteria

Please contact Akshay Bhavsar to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.

Sites

  • California

    • GSK Investigational Site, Los Angeles, California, 90033
    • GSK Investigational Site, Orange, California, 92868

  • Colorado

    • GSK Investigational Site, Aurora, Colorado, 80045

  • Washington

    • GSK Investigational Site, Seattle, Washington, 98109

  • Minnesota

    • GSK Investigational Site, Rochester, Minnesota, 55905

  • Missouri

    • GSK Investigational Site, St Louis, Missouri, 63110

  • Wisconsin

    • GSK Investigational Site, Madison, Wisconsin, 53792

  • Ohio

    • GSK Investigational Site, Cincinnati, Ohio, 45219

  • France

    • GSK Investigational Site, Villejuif Cedex, 94805
    • GSK Investigational Site, Lille cedex, 59037
    • GSK Investigational Site, Paris Cedex 12, 75571

  • Nordrhein-Westfalen

    • GSK Investigational Site, Moers, Nordrhein-Westfalen, 47441
    • GSK Investigational Site, Moers, Nordrhein-Westfalen, 47441

  • Spain

    • GSK Investigational Site, Las Palmas De Gran Canaria, 35016
    • GSK Investigational Site, Valencia, 46014
Powered by SC CTSI